Literature DB >> 17405985

Copper:caeruloplasmin ratio.

Patrick J Twomey1, Adie Viljoen, Ivan M House, Timothy M Reynolds, Anthony S Wierzbicki.   

Abstract

Investigation of copper status can be a diagnostic challenge. The non-caeruloplasmin-bound copper (NCC) has deficiencies; accordingly, the copper:caeruloplasmin ratio has been suggested as an alternative index of copper status. A reference interval for this index was derived. In addition to making the interpretation of copper easier, the copper:caeruloplasmin ratio should also enable adjustment for relatively high caeruloplasmin concentrations without recourse to producing gender- and age-derived intervals. The copper:caeruloplasmin ratio has weaknesses similar to those identified for NCC in that immunological methods used for caeruloplasmin can cross react with apocaeruloplasmin and there is no standardised method for caeruloplasmin. Caeruloplasmin assays also have uncertainty from precision, bias and specificity and, accordingly, method-related differences may have a large effect on the copper:caeruloplasmin ratio in a manner similar to the NCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17405985      PMCID: PMC2001115          DOI: 10.1136/jcp.2006.041756

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

Review 1.  ACP Best Practice No 163. Wilson's disease: acute and presymptomatic laboratory diagnosis and monitoring.

Authors:  D Gaffney; G S Fell; D S O'Reilly
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

2.  Use of CRM 470/RPPHS has not achieved true consensus for ceruloplasmin measurement.

Authors:  Robert Beetham; Peter White; Pamela Riches; David Bullock; Finlay MacKenzie
Journal:  Clin Chem       Date:  2002-12       Impact factor: 8.327

3.  Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin-bound copper in routine clinical practice.

Authors:  Patrick J Twomey; Adie Viljoen; Ivan M House; Timothy M Reynolds; Anthony S Wierzbicki
Journal:  Clin Chem       Date:  2005-08       Impact factor: 8.327

4.  Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice.

Authors:  P J Twomey; A Viljoen; I M House; T M Reynolds; A S Wierzbicki
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

5.  Urinary copper excretion in type 2 diabetic patients with nephropathy.

Authors:  S Ito; H Fujita; T Narita; T Yaginuma; Y Kawarada; M Kawagoe; T Sugiyama
Journal:  Nephron       Date:  2001-08       Impact factor: 2.847

6.  Copper deficiency myeloneuropathy and pancytopenia secondary to overuse of zinc supplementation.

Authors:  J Rowin; S L Lewis
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

Review 7.  Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically.

Authors:  J M Walshe
Journal:  Ann Clin Biochem       Date:  2003-03       Impact factor: 2.057

Review 8.  Review article: diagnosis and current therapy of Wilson's disease.

Authors:  P Ferenci
Journal:  Aliment Pharmacol Ther       Date:  2004-01-15       Impact factor: 8.171

9.  Effects of age and sex on copper absorption, biological half-life, and status in humans.

Authors:  P E Johnson; D B Milne; G I Lykken
Journal:  Am J Clin Nutr       Date:  1992-11       Impact factor: 7.045

10.  Copper-64 metabolism in two patients with non-Wilsonian movement disorders and copper deficiency.

Authors:  A S Wierzbicki; N Patel; K Evans; P T Lascelles
Journal:  J Neurol Sci       Date:  1993-10       Impact factor: 3.181

  10 in total
  3 in total

1.  Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson's disease.

Authors:  Karolina Dzieżyc; Tomasz Litwin; Grzegorz Chabik; Anna Członkowska
Journal:  Funct Neurol       Date:  2015 Oct-Dec

2.  Single nucleotide polymorphisms in the human ATP7B gene modify the properties of the ATP7B protein.

Authors:  Courtney J McCann; Samuel Jayakanthan; Mariacristina Siotto; Nan Yang; Maria Osipova; Rosanna Squitti; Svetlana Lutsenko
Journal:  Metallomics       Date:  2019-06-19       Impact factor: 4.526

3.  Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants.

Authors:  Rosanna Squitti; Mariacarla Ventriglia; Ilaria Simonelli; Cristian Bonvicini; Alfredo Costa; Giulia Perini; Giuliano Binetti; Luisa Benussi; Roberta Ghidoni; Giacomo Koch; Barbara Borroni; Alberto Albanese; Stefano L Sensi; Mauro Rongioletti
Journal:  Biomolecules       Date:  2021-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.